Clinical Trials at Vanderbilt-Ingram Cancer Center
At Vanderbilt-Ingram Cancer Center, we are dedicated to developing new and better cancer care options through continued commitment to clinical trials. Patients seek out our center because of our extensive range of trials, expert specialists, active Phase I program and supportive team that’s at their side every step of the way. Some goals of a clinical trial are to identify a disease or disorder, control or manage a disease, prevent an illness, cure a disease or disorder, and determine the safety or effectiveness of new drugs or treatments.
Search our open clinical trials by disease, physician/investigator, treatment type and drug names at:
Clinical Trials Information for Patients
Clinical trials are studies of promising new approaches to care, which may include new medications or an innovative technique to deliver a treatment. In fact, all of today's standard cancer treatments were once clinical trials. Learn more about the clinical trials process, safety, participation and support resources at VanderbiltHealth.com.
Clinical Trials Eligibility
If you are a patient, please contact Patient Access Services at 615-936-8422 to set up an appointment to learn about clinical trial options.
If you are a referring provider, please call 615-936-8422 or use Vanderbilt Health Connect to make referrals or communicate with your patients’ Vanderbilt Care team. If want to learn more about Vanderbilt Health Connect please contact us.
Participation
As a volunteer, you have the opportunity to be involved in clinical research that may bring about advances in science and healthcare. There are risks that you need to know about before you decide to enroll in a clinical trial. Any questions you may have about the study will be answered before you start, but before a new treatment is tested with patients it is carefully studied for several years in a laboratory and tested for safety. At Vanderbilt, clinical trials undergo a rigorous approval process both by the U.S. Food and Drug Administration (FDA) and by two separate committees at the Medical Center. Patients who qualify for a trial decide, with advice from their doctor, whether to participate in a study. The patient will learn about both the risks and benefits of the study before making a decision.
Phases of a Clinical Trial
 |
 |
Patient Testimonials
 |
 |
| Damaris Olagundoye, MD, grew up knowing that her maternal grandmother was a breast cancer survivor. She would listen as her mother talked with cousins who had also been diagnosed with the disease, but her family didn’t learn until decades later that they carried a mutation in the BRCA2 gene. Researchers at Vanderbilt-Ingram Cancer Center, where Olagundoye is a patient, are putting Black women front and center as they investigate why breast cancer is deadlier in women of African ancestry than other racial groups. Click below to read more about Dr. Olagundoye. https://momentum.vicc.org/2022/11/hidden-risks/ |
Kelsey Brauman, Courtni Hammers, and Sam Shreve are survivors of a rare cancer, who met in VICC clinic. All three women are now post-treatment and on a schedule of routine monitoring to spot any potential cancer recurrence for a minimum of 10 years. During that time, they know one thing for sure. The bond they formed due to their diagnoses will remain. They plan to continue texting, calling, checking in via Facebook posts and even meeting up when they can. Click below to read about their individual stories and collective bond. https://momentum.vicc.org/2022/04/sarcoma-sisterhood/ |
Meet our Physicians
 |
 |
| Fall 2022- "Vanderbilt-Ingram Cancer Center (VICC) physicians are leading two landmark clinical trials that have the potential to greatly expand care options for people with colorectal cancer. One offers a new option for metastatic colorectal cancer that has not responded to existing treatments. The other could bring about a paradigm shift in how rectal cancer is treated among a subset of patients. Click below to read more about these exciting new therapies" https://momentum.vicc.org/2022/11/breakthrough-therapies/ |
Spring 2022- "Ryan Merrell, MD joined the Vanderbilt faculty in August 2021 as assistant professor of Neurology and director of the Division of Neuro-Oncology, leading the charge to grow Vanderbilt University Medical Center’s nationally recognized brain tumor program. Vanderbilt’s Division of Neuro-Oncology specializes in the diagnosis and management of primary or secondary cancers affecting the brain and the neurologic complications of cancer. Click Here to read the article about Dr. Merrell" https://momentum.vicc.org/2022/04/empathetic-mindset/ |
Clinical Trials Resources for Investigators
Vanderbilt-Ingram Cancer Center provides staff and investigators with the resources they need to conduct and complete scientifically meritorious clinical trials.
Featured Clinical Trials
Vanderbilt-Ingram is at the forefront of promising new therapies, with access to over 200 open clinical trials at any given time. Through research and clinical trials, we have helped to advance the treatment of a number of cancers.
